Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2932
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
25336
CELLCEUTIX CORPORATION 1.22Down -0.06 (-4.69 %)AS
4kids
07/14/2016 4:25:36 PM
25335
1400 shares on offer at 1.22-1.26. Then nothing
Drano
07/14/2016 4:02:45 PM
25334
According to that otcmarkets site, not much
Drano
07/14/2016 3:59:41 PM
25333
Distorting other people's posts is a favorite
Drano
07/14/2016 3:57:13 PM
25332
just a piece of advice for this venue .. (SMB)
4kids
07/14/2016 3:55:54 PM
25330
One would think they have enough whining to
incubus
07/14/2016 3:48:49 PM
25329
Just made it happen. Much better.
incubus
07/14/2016 3:46:34 PM
25328
I was debating whether it was scott or booby but
Drano
07/14/2016 3:45:46 PM
25327
So the new whiner and attack dog. If you don't
(2)
incubus
07/14/2016 3:44:43 PM
25324
From the interview with Dr.B that KarinCa did
scgmck1
07/14/2016 3:39:24 PM
25323
A reminder of how to ignore a poster: you click
Drano
07/14/2016 3:34:47 PM
25322
The company has stated that there were problems
Drano
07/14/2016 3:33:45 PM
25320
Ah, gotcha. That's a trading strategy I would
Drano
07/14/2016 3:31:17 PM
25319
Drano Leo said that 6 months ago. Look the PR up.
BLDM
07/14/2016 3:31:03 PM
25318
If someone who owns both stocks saw ARTH tanking
TheDane
07/14/2016 3:27:56 PM
25317
The Bril-OM trial was the proof of concept to
Drano
07/14/2016 3:26:43 PM
25316
You must be unaware that the company announced
Drano
07/14/2016 3:24:14 PM
25315
Sounds to me like Cellceutix should have done the
BLDM
07/14/2016 3:20:19 PM
25314
They haven't done 3/5 of the patients in 14
BLDM
07/14/2016 3:17:06 PM
25313
$CTIX .. retail investors might find this data
4kids
07/14/2016 3:15:32 PM
25312
I know that you referred to UP. Read my response
(2)
Drano
07/14/2016 3:10:51 PM
25311
I didn't say what if OM fails I said UP. If UP
(1)
BLDM
07/14/2016 3:08:30 PM
25310
Not following you -- why would ARTH's problem
(1)
Drano
07/14/2016 3:06:37 PM
25309
Another stock that could have helped create the
(1)
TheDane
07/14/2016 2:59:05 PM
25308
There is no reason to suppose that any of CTIX's
Drano
07/14/2016 2:58:51 PM
25307
Not true. Less than a handful of real bashers.
BLDM
07/14/2016 2:55:36 PM
25306
From what I heard and saw, the Yahoo board isn't
sox0407
07/14/2016 2:50:47 PM
25305
You've NEVER and will NEVER see my posts there. I
BLDM
07/14/2016 2:47:35 PM
25304
OK so we found out through KarinCA that B-ABSSSI
BLDM
07/14/2016 2:45:53 PM
25303
Just wondering whether I've seen your posts over
sox0407
07/14/2016 2:43:58 PM
25302
Notice how it took out stops down to 1.12 and now
Drano
07/14/2016 2:40:59 PM
25301
I've never posted or even have an id for Ihub.
BLDM
07/14/2016 2:39:42 PM
25300
Hi Jim, I don't visit the Yahoo board. Have you
sox0407
07/14/2016 2:36:23 PM
25299
If that's true why is the stock at
TheDane
07/14/2016 2:34:47 PM
25298
Expect bungling and hope for something
TheDane
07/14/2016 2:31:43 PM
25297
We know Prurisol works and we know B-ABSSSI
BLDM
07/14/2016 2:28:11 PM
25296
Yes, both P3s can be run at the same time. My
(1)
sox0407
07/14/2016 2:27:19 PM
25295
GOOD SLEUTHING YOUNG
MMmanipulation
07/14/2016 2:21:15 PM
25294
DRANO don't tell me how to post. It was a
(1)
BLDM
07/14/2016 2:21:03 PM
25293
Here's a 5-day chart of AVXL. See how it topped
Drano
07/14/2016 1:51:04 PM
25292
That otcmarkets site is really inaccurate. If I
Drano
07/14/2016 1:48:45 PM
25291
Well, that is the high risk / high reward aspect
Loose Lips
07/14/2016 1:45:59 PM
25290
uh huh. So now we're going to just start assuming
Drano
07/14/2016 1:44:55 PM
25289
If the Ovarian trial ever kicks off. I believe we
BLDM
07/14/2016 1:44:15 PM
25288
again .. with caveats met and core holdings
4kids
07/14/2016 1:42:29 PM
25287
What happens if UP fails...I mean besides ctix
BLDM
07/14/2016 1:41:39 PM
25286
Well, I am trying to think optimistically and a
Loose Lips
07/14/2016 1:32:41 PM
25285
On a different topic: here is a link to a local
Loose Lips
07/14/2016 1:27:05 PM
25284
I've mentioned the AVXL/CTIX revolving door here
(1)
Drano
07/14/2016 1:22:21 PM
25283
I sure hope it is part of a larger well thought
Loose Lips
07/14/2016 1:09:12 PM
Newer
Older
Recent Articles
Neuronetics Welcomes Steven Pfanstiel as CFO—A New Era Begins
S&P Global Partners with Anthropic to Transform Financial Analysis
SELLAS Advances SLS009 for First-Line AML Following Phase 2 Success
Maryland Court Decision Strengthens MSP Recovery's Case Against GEICO
Transformational Leadership Change at Neuronetics Strengthens Vision
Emergent BioSolutions Sets Date for Q2 Financial Call
Plus Therapeutics Advances with REYOBIQ™ in Clinical Trial Results
Iovance Biotherapeutics Enhances Leadership with CFO Appointment
WestKam Gold Corp. Welcomes New Interim CFO and Funding Initiative
Changes to Synthetic Dyes in Ice Cream: Major Industry Impact
ProKidney and FDA Collaboration on Rilparencel Approval Insights
Mark Cuban Spotlights Political Strategies of Zohran Mamdani
Unlock Profits with AAS MINER's Smart Mining Innovation
BriaCell Expands Cancer Research Collaborations with Mayo Clinic
Abeona Therapeutics Expands Access to ZEVASKYN Gene Therapy
Mill Creek Residential Opens Modera St. Paul for New Residents
Nexxen Expands CTV Opportunities Through Partnership with VIDAA
Alidade Capital Expands Leadership in Net Lease Investments
Emergent BioSolutions Plans Q2 Financial Reporting Events
Rhode Island's New Law Shields Homeowners from Bad Contracts
Iovance Biotherapeutics Welcomes Corleen Roche as CFO
Insights on Trade Desk Inc and Other Market Movers Today
Sky Quarry Embarks on Innovative Digital Asset Strategy
Canada Nickel Unveils Promising Mineral Resource Estimates
Westgate Energy's Strategic Advances in Oil Production and Market Growth
Spectral Capital Expands Portfolio with 42 Telecom Acquisition
GIBO Holdings Innovates Monetization for Short-Drama Platforms
Palatin Advances Obesity Research with PL7737: Key Findings
Exciting New Bybit Promotion Offers 20,000 USDT Weekly Rewards
BlackRock Sees Significant Revenue Growth and AUM Increase
Innovative Partnership to Enhance Marine Retail Solutions
Breakthrough Advances in Weight Loss Solutions by Palatin
Western Copper and Gold's Essential ESE Project Update
Coveo's Strategic Moves: Renewing Your Investment Confidence
OSR Holdings Welcomes Dr. Niethammer as New CMO of Vaximm
PSEG To Share Insights on Q2 2025 Financial Performance
GIBO Click Achieves Milestone with DramaFlow Monetization Engine
Freightos Achieves Record Performance in Second Quarter
7-Eleven Unveils Flavorful New Menu for Summer Enjoyment
Mokas Coffee & Eatery Announces Exciting Franchise Plans
Rhode Island's New Law Shields Homebuyers from Unfair Practices
S&P Global and Anthropic Collaborate to Transform Financial Data Access
Eshbal Expands U.S. Market Reach with Strategic Moves
YMCA's Ongoing Recovery Empowered by Community Support
Navigating Uncertain Markets: Insights from M4Markets Podcast
Aurora Spine Engages at Prestigious Pain Management Conference
Maryland Court Victory Boosts MSP Recovery's Legal Efforts
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Therapy Development
Goodfood Market Corp to Announce Q3 Fiscal 2025 Results Soon
Flagship Communities REIT Declares July 2025 Cash Distribution